Cellular and molecular aspects of familial hypertrophic cardiomyopathy caused by mutations in the cardiac troponin I gene

By Gomes Aldrin V.   Potter James D.  

Molecular and Cellular Biochemistry, Vol. 263, Iss. 1, 2004-08 ,pp. : 99-114

Springer Publishing Company

Access to resources Recommend Favorite

A mouse model of familial hypertrophic cardiomyopathy caused by a -tropomyosin mutation

By Prabhakar R.   Petrashevskaya N.   Schwartz A.   Aronow B.   Boivin G.P.   Molkentin J.D.   Wieczorek D.F.  

Molecular and Cellular Biochemistry, Vol. 251, Iss. 1-2, 2003-09 ,pp. : 33-42

Springer Publishing Company

Access to resources Recommend Favorite

A low prevalence of MYH7 / MYBPC3 mutations among Familial Hypertrophic Cardiomyopathy patients in India

By Bashyam Murali  

Molecular and Cellular Biochemistry, Vol. 360, Iss. 1-2, 2012-01 ,pp. : 373-382

Springer Publishing Company

Access to resources Recommend Favorite

Mutations in &bgr;-Myosin S2 that cause Familial Hypertrophic Cardiomyopathy (FHC) Abolish the Interaction with the Regulatory Domain of Myosin-binding Protein-C

By Gruen M.   Gautel M.  

Journal of Molecular Biology, Vol. 286, Iss. 3, 1999-02 ,pp. : 933-949

Academic Press

Access to resources Recommend Favorite

Calcium- and Magnesium-Dependent Interactions between the C-Terminus of Troponin I and the N-Terminal, Regulatory Domain of Troponin C

By Digel J.   Abugo O.   Kobayashi T.   Gryczynski Z.   Lakowicz J.R.   Collins J.H.  

Archives of Biochemistry and Biophysics, Vol. 387, Iss. 2, 2001-03 ,pp. : 243-249

Elsevier

Access to resources Recommend Favorite